
GlaxoSmithKline (GSK), Imperial College London (ICL) and the Medical Research Centre (MRC) have established a unique research collaboration in medical imaging, creating a Clinical Imaging Centre (CIC) based at Hammersmith Hospital in West London.
The GSK CIC will use and advance the latest technologies in magnetic resonance imaging (MRI) and positron emission tomography (PET). Research will focus on cancer, stroke, neurological and psychiatric diseases.
GSK is one of the world's leading research-based pharmaceutical and healthcare companies and is committed to improving the quality of human life by enabling people to do more, feel better and live longer.
